No Record Found
Sector
PharmaceuticalsOpen
₹19.06Prev. Close
₹19.06Turnover(Lac.)
₹2.92Day's High
₹19.5Day's Low
₹19.0652 Week's High
₹40.1852 Week's Low
₹16.75Book Value
₹9.63Face Value
₹10Mkt Cap (₹ Cr.)
32.8P/E
56.21EPS
0.34Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 17.17 | 16.31 | 15.5 | 15.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -0.62 | -1.46 | -2.02 | -2.84 |
Net Worth | 16.55 | 14.85 | 13.48 | 12.66 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 14.53 | 26.42 | 20.09 | 13.98 |
yoy growth (%) | -44.98 | 31.48 | 43.72 | 14.03 |
Raw materials | -11.75 | -23.52 | -18.34 | -12.46 |
As % of sales | 80.87 | 89.02 | 91.3 | 89.15 |
Employee costs | -0.41 | -0.46 | -0.34 | -0.36 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 0.19 | 0.18 | 0.24 | 0.18 |
Depreciation | -0.22 | -0.27 | -0.1 | -0.13 |
Tax paid | -0.09 | -0.21 | -0.12 | -0.06 |
Working capital | 0.37 | 2.88 | 0.4 | -7.57 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -44.98 | 31.48 | 43.72 | 14.03 |
Op profit growth | -40.79 | 31.2 | -388.5 | -67.98 |
EBIT growth | -13.81 | -2.85 | 12.77 | 1,144.77 |
Net profit growth | -399.48 | -126.14 | 5.66 | -67.83 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,620.25 | 78.05 | 3,88,752.25 | 753.53 | 0.99 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,050.65 | 68.76 | 1,60,625.75 | 557 | 0.49 | 2,357 | 561.08 |
Cipla Ltd CIPLA | 1,559.25 | 24.38 | 1,25,949.05 | 1,303.13 | 1.03 | 4,501.66 | 397.38 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,543.6 | 60.33 | 1,19,926.14 | 551 | 0.17 | 2,567 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,310.95 | 15.87 | 1,09,412.84 | 2,961.2 | 0.61 | 7,788.7 | 345.75 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Jay Kothari
Executive Director
Anju Kothari
Independent Director
Pooja Bhandari
Independent Director
Athak Mahajan
Independent Director
Rajiv Kumar
Company Sec. & Compli. Officer
Arpita Vijayvargiya
01 Panjon Farm House,
Airport Bijasan Road,
Madhya Pradesh - 452005
Tel: -
Website: http://www.panjon.in
Email: bse@panjon.in; info@panjon.in
D-153/A 1st Flr,
Okhla Industrial Are, Phase-I,
New Delhi-110020
Tel: 91-11-26812682
Website: www.skylinerta.com
Email: admin@skylinerta.com/virenr@skylinerta.com
Summary
Incorporated in Dec.83 Panjon Limited became public in 1992. The Company was promoted by Nagin Kothari and Manoj Kothari. The Company is a leading FMCG company. It has marked its presence with signifi...
Read More
Reports by Panjon Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.